Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$491M |
| 2 |
Microsoft
MSFT
|
+$352M |
| 3 |
Apple
AAPL
|
+$346M |
| 4 |
Janus Henderson Mortgage-Backed Securities ETF
JMBS
|
+$333M |
| 5 |
Cisco
CSCO
|
+$324M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Novartis
NVS
|
+$409M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$374M |
| 3 |
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
|
+$347M |
| 4 |
ATVI
Activision Blizzard
ATVI
|
+$343M |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$334M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.03% |
| 2 | Financials | 12.41% |
| 3 | Healthcare | 11.8% |
| 4 | Consumer Discretionary | 10.03% |
| 5 | Industrials | 9.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1701
Healthcare Services Group
HCSG
$1.45B
| $16.6M | ﹤0.01% |
1,599,981
+111,625
| +7% | +$1.11M |
|
1702
Central Pacific Financial
CPF
$1B
| $16.6M | ﹤0.01% |
842,611
+20,929
| +3% | +$366K |
|
1703
Twist Bioscience
TWST
$7.86B
| $16.5M | ﹤0.01% |
448,232
+5,728
| +1% | +$132K |
|
1704
BancFirst
BANF
$3.89B
| $16.5M | ﹤0.01% |
169,562
+12,457
| +8% | +$1.09M |
|
1705
Safety Insurance
SAFT
$1.52B
| $16.5M | ﹤0.01% |
216,496
+9,803
| +5% | +$740K |
|
1706
Marten Transport
MRTN
$1.24B
| $16.4M | ﹤0.01% |
780,794
+27,507
| +4% | +$525K |
|
1707
IonQ
IONQ
$18.2B
| $16.4M | ﹤0.01% |
1,321,275
+29,577
| +2% | +$381K |
|
|
VISN
1708
Vistance Networks Inc
VISN
$2.62B
| $16.3M | ﹤0.01% |
5,790,900
+1,280,636
| +28% | +$2.77M |
|
1709
Hawkins
HWKN
$2.67B
| $16.3M | ﹤0.01% |
231,772
-1,421
| -0.6% | -$88.4K |
|
1710
Nelnet
NNI
$4.55B
| $16.3M | ﹤0.01% |
184,806
-5,184
| -3% | -$449K |
|
1711
Impinj
PI
$5.46B
| $16.3M | ﹤0.01% |
180,847
+6,810
| +4% | +$489K |
|
1712
Pathward Financial
CASH
$1.79B
| $16.3M | ﹤0.01% |
307,377
+3,579
| +1% | +$176K |
|
1713
Shenandoah Telecom
SHEN
$744M
| $16.3M | ﹤0.01% |
751,915
+42,747
| +6% | +$957K |
|
1714
Scholastic
SCHL
$784M
| $16.2M | ﹤0.01% |
430,679
+20,961
| +5% | +$802K |
|
1715
Celldex Therapeutics
CLDX
$3.35B
| $16.2M | ﹤0.01% |
409,391
+47,844
| +13% | +$1.41M |
|
|
1716
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
$10.8B
| $16.2M | ﹤0.01% |
545,177
-11,798,104
| -96% | -$347M |
|
1717
Federated Hermes
FHI
$4.74B
| $16.2M | ﹤0.01% |
479,008
+1,296
| +0.3% | +$42.2K |
|
|
ATSG
1718
DELISTED
Air Transport Services Group
ATSG
| $16.1M | ﹤0.01% |
916,824
+84,280
| +10% | +$1.5M |
|
1719
Supernus Pharmaceuticals
SUPN
$2.74B
| $16.1M | ﹤0.01% |
555,930
+24,684
| +5% | +$654K |
|
|
CPRX
1720
DELISTED
Catalyst Pharmaceutical
CPRX
| $16.1M | ﹤0.01% |
956,333
+35,006
| +4% | +$479K |
|
1721
State Street SPDR Portfolio Emerging Markets ETF
SPEM
$17.7B
| $16M | ﹤0.01% |
453,151
-100,700
| -18% | -$3.42M |
|
1722
Atlanta Braves Holdings Series B
BATRK
$3.41B
| $16M | ﹤0.01% |
405,334
+4,203
| +1% | +$153K |
|
1723
Delek US
DK
$4.18B
| $16M | ﹤0.01% |
620,957
+13,238
| +2% | +$350K |
|
|
AVDX
1724
DELISTED
AvidXchange
AVDX
| $16M | ﹤0.01% |
1,288,173
+23,506
| +2% | +$235K |
|
|
ACH
1725
Accendra Health
ACH
$84.6M
| $15.9M | ﹤0.01% |
825,142
+38,393
| +5% | +$695K |
|
Similar funds
Charles Schwab's Q4 2023 Portfolio in Review
As of Q4 2023, Charles Schwab held 3,619 positions worth $394B, up 13% from $349B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Trading was light in Q4 2023: portfolio turnover was 3.5%. Charles Schwab opened 44 new positions and exited 81, leaving the 3,619-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q4 2023 buy was Janus Henderson Mortgage-Backed Securities ETF: 7,612,323 shares worth $350M.
- Charles Schwab added most to Merck in Q4 2023, an estimated $491M increase.
- Charles Schwab's biggest Q4 2023 reduction was Novartis, cutting an estimated $409M.
- Charles Schwab fully exited Activision Blizzard in Q4 2023, selling an estimated $343M.
- Charles Schwab's ten largest holdings make up 19% of its $394B portfolio in Q4 2023.
- Charles Schwab opened 44 new positions and closed 81 in Q4 2023.
- Charles Schwab's portfolio value rose 13% quarter-over-quarter to $394B.
Based on Charles Schwab's 13F filing for Q4 2023, filed 6 Feb 2024.